Organization | Ukrainian Medical Stomatological Academy

Ukrainian Medical Stomatological Academy Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial

2012

NCT03011775

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2017

Timeline

NOW

Now

Alternative names

Ukrainian Medical Stomatological Academy | Ukrainian Medical Stomatological Academy Poltava, Ukraine

Active Ingredients

Drugs in Phase 4 Trials (6)

acetylsalicylic acid (aspirin) (1 trial)

bisoprolol (zebeta) (1 trial)

isosorbide (isordil) (1 trial)

pioglitazone (actos) (1 trial)

ramipril (altace) (1 trial)

rosuvastatin (crestor) (1 trial)

Drugs in Phase 3 Trials (2)

arginine (1 trial)

ornithine (1 trial)

Drugs in Other Trials (1)

azithromycin (zithromax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Atherosclerosis (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Heart Diseases (Phase 4)

Insulin Resistance (Phase 4)

Metabolic Syndrome (Phase 4)

Myocardial Ischemia (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 3
# of Trial APIs: 9